Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on cytarabine (Ara-C) in children with acute promyelocytic leukemia (APL) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)

Snippet

Sponsor: Xiaofan Zhu | Conditions: Leukemia | Phase 4 | Status: COMPLETED | Results posted: 2021-02-21